抗体
试剂盒
多肽
蛋白
组织芯片
产品中心
Product Center
Research Grade Cabiralizumab
All
TD-HY035016_1.jpg
TD-HY035016_2.jpg
- Catalog： TD-HY035016
- Clonality： mAb
- Application： Research Grade Biosimilar
- Synonyms： FPA-008,CAS:1613144-80-1
-
规格：
1mg
-
价格：
¥询价
定制服务咨询
Research Grade Cabiralizumab
| Catalog No. | TD-HY035016 |
|---|---|
| Species reactivity | Human |
| Applications | Research Grade Biosimilar |
| Host species | Humanized |
| Isotype | IgG4-kappa |
| Expression system | Mammalian Cells |
| Clonality | Monoclonal |
| Target | CD115, CSF-1 receptor, CSF1R, M-CSF-R, CSF-1-R, Proto-oncogene c-Fms, Macrophage colony-stimulating factor 1 receptor, CSF-1R, FMS |
| Endotoxin level | Please contact the lab for this information. |
| Purity | >95% purity as determined by SDS-PAGE. |
| Purification | Protein A/G, purified from cell culture supernatant. |
| Accession | P07333 |
| Form | Liquid |
| Storage buffer | 0.01M PBS,pH7.4. |
| Stability and Storage | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C for short-term storage (1-2 weeks). Store at -20°C for up to 12 months. For long-term storage, store at -80°C. |
| Alternate Names | FPA-008,CAS:1613144-80-1 |
| Background | Cabiralizumab (FPA 008) is an anti-CSF1R monoclonal antibody (MAb). Cabiralizumab enhances T cell infiltration and antitumor T cell immune responses. Cabiralizumab inhibits the activation of osteoclasts and blocks bone destruction, and can be used in the research of rheumatoid arthritis (RA). Cabiralizumab can combine with Nivolumab (HY-P9903) for lung cancer research. |
| Note | For research use only. Not for use in clinical or therapeutic applications. |
|
|
Detects CD115/CSF1R in indirect ELISAs. |
|
|
SDS-PAGE for Research Grade Cabiralizumab. |